Information de base

Numéro de Référence

00004272341

Organisation émettrice

Provincial Health Services Authority BC

Type d’appel d’offres

DDP - Demande de proposition (Formel)

Numéro d’appel d’offres

205636

Titre

RFP PHSA 13818 Provincial Pneumococcal Vaccine Product(s)

Code d’identité d’origine

SCRIBE

Détails

Emplacement

Colombie Britannique

Type d’achat

Non-mentionné

Dates

Publication

2024-10-18 14h54:00 HAE

Date de fermeture

2024-11-20 15h00:00 HNE

Information du contact

Provincial Health Services Authority (Incl. BCCSS)

PHSA02921@phsa.ca

Description

This RFP is being issued by Provincial Health Services Authority (“ PHSA”) to identify a Proponent(s) to enter into a non-exclusive Contract between a Proponent(s) and the PHSA, for the supply of vaccine(s) for the prevention of pneumococcal infections with a focus on invasive pneumococcal disease (IPD) as described in Appendix G, Specifications (the “ Product(s)”) to the health authorities.
The Province of BC (the “Province”) currently uses the Prevnar 13 (manufactured by Pfizer Inc. or “Pfizer”) and Pneumovax 23 (manufactured by the Merck Group or “Merck”) vaccines to provide protection against pneumococcal infections. Both Pfizer and Merck are able to respond to this RFP.
The BC Centre for Disease Control (“BC CDC”), a program of the Provincial Health Services Authority, provides provincial and national leadership in disease surveillance, detection, treatment, prevention and consultation.

Afficher davantage

Dérogation All amendments to the associated notice, including amended documents, plans and specifications (where applicable), are issued on bcbid.gov.bc.ca. MERX asks that you refer to bcbid.gov.bc.ca notice for these amendments. MERX stipulates that potential bidders may also be required to register with the buying authority as a bidder/plan taker. The contact information can be found within the notice abstract.